Effect of repeated three-monthly albendazole treatments on malaria and allergic disease
Not Applicable
Completed
- Conditions
- Helminth and malaria parasitic diseasesInfections and Infestations
- Registration Number
- ISRCTN83830814
- Lead Sponsor
- Royal Netherlands Academy of Arts and Sciences (Netherlands)
- Brief Summary
2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23526959 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/30091979 2019 gut microbiome results in: https://www.ncbi.nlm.nih.gov/pubmed/31781154 (added 02/12/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 4004
Inclusion Criteria
1. Both males and females
2. Age >=2 years. No upper age limit.
3. Those who have given informed consent
Exclusion Criteria
1. History of chronic liver, heart or central nervous system (CNS) disease
2. Allergy to albendazole
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method